February 2025 FDA Recall Metformin Hydrochloride by A-s Medication Solutions Llc
D-0292-2025 - Presence of Foreign Tablets/Capsules.
This Class II drug recall was voluntarily initiated by A-s Medication Solutions Llc on February 25, 2025 for the product Metformin Hydrochloride. The FDA reported the reason for recall as presence of foreign tablets/capsules.. The product was distributed Nationwide and the recall is currently ongoing.
Recall Number: D-0292-2025
Presence of Foreign Tablets/Capsules.
02-25-2025
04-02-2025
411 180-count bottles
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
A-S Medication Solutions LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide in U.S.
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
METFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MG, 180 TABLETS, Packaged BY: A-S Medication Solutions, Libertyville, IL 60048 NDC 50090-1494-3.
Batch or Lot Expiration Information
Lot# 4260340; Exp.12/31/2025.
